Diagnosing HPV-Related Oropharyngeal Cancers: The Need to Speak a Common Language
Journal: Global Journal of Cancer Therapy (Vol.3, No. 1)Publication Date: 2017-12-30
Authors : Daniela Russo Francesco Merolla Gennaro Ilardi Silvia Varricchio Danila Caroppo Virginia Napolitano Massimo Mascolo; Stefania Staibano;
Page : 008-011
Keywords : ;
Abstract
Oral cavity squamous cell cancer (OSCC) and Oropharynx squamous cell carcinoma (OPSCC) are the most frequent forms of Head and Neck Cancers (HNCs) [1]. About 300,000 new cases of oral cancers are being counted yearly worldwide, having registered an increase of incidence of 225% in U.S.A. in the last 20 years, with about 50% of related deaths [2,3]. The relevant advances in treatments of OSCC during the last decades, allowed updated surgery techniques, robotic surgery, intensive induction chemotherapy and hyperfractionated radiotherapy to be currently applied to the advanced cases. Unfortunately, most of these therapies often carry severe acute and chronic side effects, heavily impacting on patients' quality of life.
Other Latest Articles
- Is it Time for the Introduction of Colostomy Free Survival in Rectal Cancer Patients
- Primary Spindle Cell Rhabdomyosarcoma of Prostate: A Case Report with Review of Literature
- The Paradoxes of Neoantigenes in Predicting Better Prognosis of Cancer Patients
- Gamma-Delta T Cell Acute Lymphoblastic Leukemia: A Single-Center Experience
- A Study on Usage of Smartphone Among Engineering and Management Students in Pune
Last modified: 2018-10-05 21:05:05